Feasibility of metal stent for removal of common bile stones in patients with dual antiplatelet therapy
Not Applicable
Recruiting
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0002151
- Lead Sponsor
- Chonnam National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
1. Patients with common bile duct stones taking dual antiplatelet agents
(Dual antiplatelet agents: aspirin + clopidogrel or aspirin + prasugrel)
2. Patients who agreed to the informed consent
Exclusion Criteria
1. Patients who did not agree to the informed conset
2. Patients with severe psychiatric disorders
3. Patients with severe comorbidity (end-stage renal disease, advanced chronic obstructive pulmonary disease, severe heart failure)
4. Patient with history of anaphylaxis to contrast agents
5. Patients with previous endoscopic sphincterotomy
6. Pregnant patients
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method post-ERCP bleeding after common bile duct stone removal
- Secondary Outcome Measures
Name Time Method Success rates of common bile duct stone removal ;Total procedure time of common bile duct stone removal ;post-ERCP complications other than bleeding